Spinal malignant triton tumor in a patient with neurofibromatosis type 1

Authors

Sevgi Kulaklı, Fazıl Kulaklı, İlker Fatih Sarı, Samet Tatlı, İlker İlhanlı, Canan Çelik
  • Sevgi Kulaklı (Author) Department of Dermatology, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey https://orcid.org/0000-0001-7886-1060
  • Fazıl Kulaklı (Author) Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey https://orcid.org/0000-0003-0275-7093
  • İlker Fatih Sarı (Author) Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey https://orcid.org/0000-0002-7998-8992
  • Samet Tatlı (Author) Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey https://orcid.org/0000-0002-4050-0873
  • İlker İlhanlı (Author) Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey https://orcid.org/0000-0002-7998-8992
  • Canan Çelik (Author) Department of Physical Medicine and Rehabilitation, Giresun University School of Medicine, Prof. Dr. İlhan Özdemir Training and Research Hospital, Giresun, Turkey https://orcid.org/0000-0001-9418-5840
https://doi.org/10.18621/eurj.464297
No abstract available.
malignant triton tumor, Neurofibromatosis, spinal nerve

[1] Jouhilahti EM, Peltonen S, Heape AM, Peltonen J. The pathoetiology of neurofibromatosis 1. Am J Pathol 2011;178:1932-9.

[2] Engel EE, Brassesco MS, Valera ET, Barbosa MHN,Yamashita MEAS, Scrideli CA, et al. Clinico-genetic aspects of a pediatric non-neurofibromatosis type 1 malignant triton tumor with loss of chromosome X. Pediatr Blood Cancer 2012;59:1320-3.

[3] Kamran SC, Howard SA, Shinagare AB, Krajewski KM. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location. EJSO 2013;39:46-52.

[4] McConnell YJ, Giacomantonio CA. Malignant triton tumors--complete surgical resection and adjuvant radiotherapy associated with improved survival. J Surg Oncol 2012;106:51-6.

[5] Lee MJ, Stephenson DA. Recent developments in neurofibromatosis type 1. Curr Opin Neurol 2007;20:135-41.

[6] Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol 2012;19:878-85.

[7] Grobmyer SR, Reith JD, Shahlaee A, Bush CH, Hochwald SN. Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations. J Surg Oncol 2008;97:340-9.

[8] Ferner RE, Gutmann DG. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis 1. Cancer Res 2002;62:1573-7.

[9] Moretti VM, Crawford EA, Staddon AP, Lackman RD, Ogilvie CM.. Early outcomes for malignant peripheral nerve sheath tumor treated with chemotherapy. Am J Clin Oncol 2011;34:417-21.

There are 9 references in total.
1.
Kulaklı S, Kulaklı F, Sarı İlker F, Tatlı S, İlhanlı İlker, Çelik C. Spinal malignant triton tumor in a patient with neurofibromatosis type 1. Eur Res J. 2019;5(4):719-721. doi:10.18621/eurj.464297

Downloads

Article Information

  • Article Type Letter to the Editor
  • Submitted February 21, 2026
  • Published July 3, 2019
  • Issue Vol. 5 No. 4 (2019)
  • Section Letter to the Editor
  • File Downloads 868
  • Abstract Views 216
  • Altmetrics
  • Share
Download data is not yet available.